KRAS and metastatic malignant neoplasm in the lymph nodes: Next, in order to further characterize the M2 cell subsets present in lung tumors we compared the profile of CD163+/CD206+ cells isolated from chemoresistant patients with lung or lymph node metastasis with wild type (WT) or mutant (MT) Kras status (Fig. 2C,D).